AU Stock MarketDetailed Quotes
NEU Neuren Pharmaceuticals Ltd
- 14.050
- -0.510-3.50%
20min DelayMarket Closed Oct 4 16:00 AET
1.83BMarket Cap11.69P/E (Static)
14.420High13.940Low454.63KVolume14.380Open14.560Pre Close6.42MTurnover25.95052wk High0.41%Turnover Ratio130.07MShares10.02052wk Low0.944EPS TTM1.56BFloat Cap65.000Historical High11.69P/E (Static)110.82MShs Float0.060Historical Low1.202EPS LYR3.30%Amplitude--Dividend TTM5.74P/B1Lot Size--Div YieldTTM
Neuren Pharmaceuticals Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Dec 30, 2023 | (Q4)Dec 30, 2023 | (FY)Dec 30, 2022 | (Q4)Dec 30, 2022 | (FY)Dec 30, 2021 | (Q4)Dec 30, 2021 | (FY)Dec 30, 2020 | (Q4)Dec 30, 2020 | (FY)Dec 30, 2019 | (Q4)Dec 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 469.62%155.7M | 469.62%155.7M | 2.51%27.33M | 2.51%27.33M | 43.38%26.66M | 43.38%26.66M | 91.88%18.6M | 91.88%18.6M | -58.89%9.69M | -58.89%9.69M |
| -Cash and cash equivalents | -57.39%11.65M | -57.39%11.65M | 2.51%27.33M | 2.51%27.33M | 43.38%26.66M | 43.38%26.66M | 91.88%18.6M | 91.88%18.6M | -58.89%9.69M | -58.89%9.69M |
| -Accounts receivable | ---- | ---- | ---- | ---- | --5.07K | --5.07K | ---- | ---- | -97.85%9.1K | -97.85%9.1K |
| -Other receivables | 281.53%1.87M | 281.53%1.87M | 21.09%489.82K | 21.09%489.82K | -10.22%404.5K | -10.22%404.5K | 193.87%450.55K | 193.87%450.55K | -75.97%153.32K | -75.97%153.32K |
| Total current assets | 472.35%168.39M | 472.35%168.39M | 1.35%29.42M | 1.35%29.42M | 51.37%29.03M | 51.37%29.03M | 90.29%19.18M | 90.29%19.18M | -62.17%10.08M | -62.17%10.08M |
| Non current assets | ||||||||||
| Non current note receivables | --525.28K | --525.28K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Regulatory assets | 1,225.36%9.82M | 1,225.36%9.82M | -28.23%740.85K | -28.23%740.85K | 77.83%1.03M | 77.83%1.03M | 50.21%580.49K | 50.21%580.49K | -58.98%386.44K | -58.98%386.44K |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| -accounts payable | 162.01%459.88K | 162.01%459.88K | -1.17%175.52K | -1.17%175.52K | 38.32%177.6K | 38.32%177.6K | -46.06%128.4K | -46.06%128.4K | -82.17%238.03K | -82.17%238.03K |
| -Total tax payable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Current provisions | 218.47%1.52M | 218.47%1.52M | --476.21K | --476.21K | ---- | ---- | ---- | ---- | ---- | ---- |
| Current deferred liabilities | --25.29M | --25.29M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Current liabilities | 2,452.20%29.13M | 2,452.20%29.13M | 96.11%1.14M | 96.11%1.14M | 0.54%582.1K | 0.54%582.1K | 47.94%578.95K | 47.94%578.95K | -80.17%391.34K | -80.17%391.34K |
| Non current liabilities | ||||||||||
| Non current accrued expenses | 105.06%29.3K | 105.06%29.3K | 64.23%14.29K | 64.23%14.29K | 13.14%8.7K | 13.14%8.7K | 9.82%7.69K | 9.82%7.69K | 250.04%7K | 250.04%7K |
| Total non current liabilities | 2,452.20%29.13M | 2,452.20%29.13M | 96.11%1.14M | 96.11%1.14M | 0.54%582.1K | 0.54%582.1K | 47.94%578.95K | 47.94%578.95K | -80.17%391.34K | -80.17%391.34K |
| Shareholders'equity | ||||||||||
| Share capital | 3.36%117.95M | 3.36%117.95M | -6.06%114.11M | -6.06%114.11M | 8.54%121.48M | 8.54%121.48M | 26.45%111.92M | 26.45%111.92M | -29.99%88.51M | -29.99%88.51M |
| -common stock | 3.36%117.95M | 3.36%117.95M | -6.06%114.11M | -6.06%114.11M | 8.54%121.48M | 8.54%121.48M | 26.45%111.92M | 26.45%111.92M | -29.99%88.51M | -29.99%88.51M |
| Gains losses not affecting retained earnings | 15.30%-4.3M | 15.30%-4.3M | 25.92%-5.07M | 25.92%-5.07M | 13.38%-6.85M | 13.38%-6.85M | -32.83%-7.91M | -32.83%-7.91M | 29.94%-5.95M | 29.94%-5.95M |
| Total equity | 473.96%168.94M | 473.96%168.94M | 1.37%29.43M | 1.37%29.43M | 51.35%29.04M | 51.35%29.04M | 90.23%19.19M | 90.23%19.19M | -62.14%10.09M | -62.14%10.09M |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data